AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇹🇳

N-BUTYLHYOSCINE BROMURE in Tunisia

9 products registered with DPM 0 active, 9 expired

Brand / ProductReg. No.HolderStatusExpires
BUSCOPAN
Comprime enrobé / 10 MG
9003254HSIPHATexpired18 Jul 2012
SPASMOPAN
Solution injectable / 20 MG
5063116HAPMexpired11 Apr 2002
BUSCOPAN
Solution injectable / 20 MG
ST9003252AHSIPHATexpired1 Dec 1994
BUSCOPAN
Comprimé / 10 MG
9003253AHSIPHATexpired1 Dec 1994
BUSCOPAN
Suppositoire / 10 MG
9003251BHSIPHATexpired22 Nov 1994
BUSCOPAN
Comprime enrobé / 10 MG
9003253BSIPHATexpired23 Jun 1993
BUSCOPAN
Suppositoire / 10 MG
9003251BSIPHATexpired5 Dec 1992
BUSCOPAN
Solution injectable / 20 MG
ST9003252BSIPHATexpired5 Dec 1992
SPASMOPAN
Solution injectable / 20 MG
5063113APMexpired4 Jan 1991

N-BUTYLHYOSCINE BROMUREDPM Registration Details

DPM (Tunisia) has 9 registered products containing N-BUTYLHYOSCINE BROMURE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.

Track N-BUTYLHYOSCINE BROMURE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

N Butylhyoscine Bromure — Tunisia (DPM) | AfricaRegulatory